Coronaviruses
The U.S. Food and Drug Administration has announced several key updates, including the approval of COMIRNATY (COVID-19 Vaccine, mRNA) for individuals between 12 and 15 years old, as well as the finalization of guidance for animal food facilities to develop a food safety plan. The agency has also authorized
Coronaviruses
Researchers from the University of Business and Technology have explored a within-host model of SARS-CoV-2/malaria coinfection, analyzing the interactions between uninfected and infected red blood cells, free SARS-CoV-2 particles, and antibodies. The study concluded that the shared immune response reduces the concentrations of malaria merozoites and SARS-CoV-2 particles in
COVID-19
A new study on COVID-19, conducted by researchers at Clemson University, has introduced a significant breakthrough in diagnostic testing. The study focused on developing a multiplex RT-qPCR diagnostic assay for population surveillance of COVID-19 in closed populations, such as residential universities. The researchers utilized open-source liquid handling robots and thermocyclers
COVID-19
Researchers from the University of Washington have made a groundbreaking discovery in the study of COVID-19, revealing that T cell receptor sequencing can identify past SARS-CoV-2 infection and correlate with neutralizing antibodies and disease severity. The study, published in JCI Insight, used small-volume blood samples from 302 individuals recovered from
Coronaviruses
Research presented by a team at George Washington University suggests that emergency health care workers, particularly nurses, are at a higher risk of depression/anxiety and burnout during the COVID-19 pandemic. The study focused on the perceived work environment and its impact on mental well-being among emergency physicians, nurses, and
Coronaviruses
The European Commission has given its approval for €374 million in Italian support to help rail freight transport companies recover from the damage caused by the coronavirus pandemic. The measure aims to compensate the companies for the lost revenue and increased costs during the pandemic, which led to a significant
Coronaviruses
Research from the Institute of Biological Information Processing in Julich, Germany, has identified the 3C-like protease (3CL[superscript]pro) as a vital component in the life cycle of SARS-CoV-2, making it a promising drug target. The study discovered that a cationic peptide from rattlesnake venom, known as crotamine, can be
Coronaviruses
The French Society of Pharmacology and Therapeutics (SFPT) released guidelines for managing drug-drug interactions with nirmatrelvir in patients treated for COVID-19. The guidelines were developed by a team of 18 clinical pharmacologists who searched the scientific literature to provide recommendations on the use of nirmatrelvir/ritonavir in combination with other
Coronaviruses
Research from the University of Manitoba has shed light on the challenges faced by students with learning disabilities (LDs) during the COVID-19 pandemic. The study, which was supported by the Social Sciences and Humanities Research Council of Canada (SSHRC) Insight Development Grant, found that students with LDs experienced significant difficulties
Coronaviruses
Aligos Therapeutics, a clinical-stage biopharmaceutical company, has announced its participation in the newly formed Metropolitan AntiViral Drug Accelerator (MAVDA), a consortium awarded a three-year, $65,141,731 grant from the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Disease (NIAID)'s Antiviral Drug Discovery
Coronaviruses
Researchers from the University of Maryland have analyzed the humoral immune responses of solid organ transplant recipients to SARS-CoV-2 vaccination, revealing an increased risk of COVID-19-related mortality in these patients. The team found that a third vaccine dose resulted in improved antibody responses against most SARS-CoV-2 variants, except the omicron
Coronaviruses
A new study on the impact of COVID-19 lockdowns on air pollution and greenhouse gas emissions has been published, highlighting significant decreases in these emissions in major polluting countries. The research, funded by the Nippon Foundation and the University of British Columbia, notes that while lockdowns have led to a
